Touchstone
Last syncNov 1, 2026, 6:55 PM ET

EHC

Encompass Health Corp Health Care Services-Hospitals Russell 3000
$135.90Close $15.8BMarket cap $93.47 – $135.9052-week range Late-januaryNext report · estimated

Highlights

Strengths

  • In a stage-2 uptrend all 8 trend conditions pass
  • Leading the market RS 81 · stronger than 81% of stocks over 12 months
  • RS line at a 1-year high outperforming the S&P 500 more than at any point this year
  • Near its high at its 52-week high

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 7, 2026
Off 12-month high 0%
1wk up 9.5% price change
1mo up 12.1% price change
12-month return up 17% market up 11% · its own down 2%
F-score — — Not assessed
Altman Z″ 2.23 Moderate risk
P/E 27.9× price / earnings
PEG 1.15 P/E / EPS growth
P/B 6.5× price / book
Earnings yield up 5.2% EBIT / enterprise value
Cheaper than 47% of the market · around average
Revenue growth up 10% year on year
EPS growth up 11% latest quarter · -20 pts
Sales growth up 10% latest quarter · +1 pts
ROE up 25% return on equity
Free cash margin up 7% $439.2M FCF
D/E 1.02 long-term debt / equity
Net debt / EBITDA 1.9×
Interest cover —EBIT / interest

Trade setup

ATR% 2.9% $3.96 a day · 2×ATR $127.98
RS 81 / 99 vs the universe
Trend 8 / 8 trend template
Relative volume 1.9× vs 50-day average
Up/down volume 1.27 50 sessions
Implied move — no scheduled report
Trend template · 8 of 8

Screen verdict

Did not qualify for any screen.

Warning signs

none flagged
  • No restatement or impairment
  • Equity positive
  • Interest covered
  • No material dilution
  • Profits tracking cash
  • Margins and revenue not shrinking
Last reported Oct 28, 2026
Results reaction Oct 28, 2026+8% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $5.9B +10% on FY2024
$0 $10B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $3.6B FY2021 · $4.0B FY2022 · $4.3B FY2023 · $4.8B FY2024 · $5.4B FY2025 · $5.9B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $566.2M +24% on FY2024
$0 $1B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $284.2M FY2021 · $412.2M FY2022 · $271.0M FY2023 · $352.0M FY2024 · $455.7M FY2025 · $566.2M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $439.2M +22% on FY2024
$0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $311.9M FY2021 · $191.2M FY2022 · $141.0M FY2023 · $267.7M FY2024 · $360.3M FY2025 · $439.2M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Net 10%
  • Free cash 7%
0% 20% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Net 8% · Free cash 9% FY2021 · Net 10% · Free cash 5% FY2022 · Net 6% · Free cash 3% FY2023 · Net 7% · Free cash 6% FY2024 · Net 8% · Free cash 7% FY2025 · Net 10% · Free cash 7%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $2.4B net debt
  • Cash
  • Long-term debt
$0 $5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $185.6M · Long-term debt $3.3B FY2021 · Cash $49.4M · Long-term debt $3.3B FY2022 · Cash $21.8M · Long-term debt $2.8B FY2023 · Cash $69.1M · Long-term debt $2.7B FY2024 · Cash $85.4M · Long-term debt $2.5B FY2025 · Cash $72.2M · Long-term debt $2.5B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 116.04m +1.9% since FY2020
116.04m 113.84m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 113.84m FY2021 · 114.21m FY2022 · 114.78m FY2023 · 115.42m FY2024 · 116.04m FY2025 · 116.04m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $3.6B $4.0B $4.3B $4.8B $5.4B $5.9B
Operating income $563.9M $559.6M $539.5M — — —
Net income $284.2M $412.2M $271.0M $352.0M $455.7M $566.2M
Net margin 8% 10% 6% 7% 8% 10%
Earnings per share $2.85 $4.11 $2.70 $3.47 $4.46 $5.54
Free cash flow $311.9M $191.2M $141.0M $267.7M $360.3M $439.2M
Free cash margin 9% 5% 3% 6% 7% 7%
Cash $185.6M $49.4M $21.8M $69.1M $85.4M $72.2M
Long-term debt $3.3B $3.3B $2.8B $2.7B $2.5B $2.5B
Shareholders' equity $1.6B $1.9B $1.3B $1.6B $2.1B $2.4B
Shares outstanding 113.84m 114.21m 114.78m 115.42m 116.04m 116.04m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 7, 2026 Quarterly ↗ Jun 30, 2026 38d
May 1, 2026 Quarterly ↗ Mar 31, 2026 31d
Feb 26, 2026 Annual ↗ Dec 31, 2025 57d
Oct 31, 2025 Quarterly ↗ Sep 30, 2025 31d
Aug 6, 2025 Quarterly ↗ Jun 30, 2025 37d
May 1, 2025 Quarterly ↗ Mar 31, 2025 31d
Feb 28, 2025 Annual ↗ Dec 31, 2024 59d
Nov 1, 2024 Quarterly ↗ Sep 30, 2024 32d
Aug 6, 2024 Quarterly ↗ Jun 30, 2024 37d
May 2, 2024 Quarterly ↗ Mar 31, 2024 32d
Feb 28, 2024 Annual ↗ Dec 31, 2023 59d
Nov 1, 2023 Quarterly ↗ Sep 30, 2023 32d

Current reports

FiledDisclosed
Oct 28, 2026 Results · Regulation FD ↗
Aug 13, 2026 Other events ↗
Aug 5, 2026 Results · Regulation FD ↗
Jun 1, 2026 Material agreement · New obligation ↗
May 15, 2026 Material agreement · Other events ↗
May 11, 2026 Shareholder vote ↗
Apr 30, 2026 Results · Regulation FD ↗
Mar 10, 2026 Material agreement · Agreement ended · New obligation ↗
Feb 5, 2026 Results · Regulation FD ↗
Feb 2, 2026 Director or officer change ↗
Dec 1, 2025 Regulation FD ↗
Oct 29, 2025 Results · Regulation FD ↗